Free Trial

agilon health (NYSE:AGL) Cut to Underperform at Bank of America

agilon health logo with Medical background

Bank of America cut shares of agilon health (NYSE:AGL - Free Report) from a buy rating to an underperform rating in a research report report published on Wednesday, MarketBeat.com reports. They currently have $3.00 price target on the stock.

Several other equities analysts have also issued reports on the company. Evercore ISI boosted their target price on agilon health from $5.50 to $7.00 and gave the stock an in-line rating in a research report on Tuesday, July 9th. Deutsche Bank Aktiengesellschaft cut their target price on shares of agilon health from $5.00 to $4.00 and set a hold rating on the stock in a report on Friday, August 9th. Benchmark reissued a buy rating and issued a $9.00 price target on shares of agilon health in a report on Thursday, August 8th. Finally, Royal Bank of Canada reaffirmed an outperform rating and set a $8.00 price objective on shares of agilon health in a research note on Wednesday, August 7th. Two research analysts have rated the stock with a sell rating, fourteen have given a hold rating and four have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of Hold and an average price target of $8.22.

Read Our Latest Stock Report on agilon health

agilon health Trading Down 2.7 %

NYSE:AGL traded down $0.10 during trading hours on Wednesday, hitting $3.57. 13,464,617 shares of the stock were exchanged, compared to its average volume of 5,024,121. The company has a quick ratio of 1.36, a current ratio of 1.36 and a debt-to-equity ratio of 0.04. agilon health has a twelve month low of $3.04 and a twelve month high of $20.37. The company has a market capitalization of $1.47 billion, a P/E ratio of -5.10 and a beta of 0.54. The company's 50 day moving average is $4.64 and its two-hundred day moving average is $5.41.

agilon health (NYSE:AGL - Get Free Report) last issued its earnings results on Tuesday, August 6th. The company reported ($0.07) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.07). agilon health had a negative net margin of 5.57% and a negative return on equity of 29.91%. The company had revenue of $1.48 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same quarter last year, the firm earned ($0.04) EPS. The company's revenue for the quarter was up 38.7% on a year-over-year basis. On average, sell-side analysts anticipate that agilon health will post -0.32 earnings per share for the current fiscal year.

Insider Buying and Selling at agilon health

In other agilon health news, CEO Steven Sell bought 20,000 shares of agilon health stock in a transaction dated Thursday, September 12th. The stock was bought at an average price of $3.36 per share, with a total value of $67,200.00. Following the completion of the transaction, the chief executive officer now owns 67,590 shares in the company, valued at approximately $227,102.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 3.20% of the company's stock.

Hedge Funds Weigh In On agilon health

Several hedge funds and other institutional investors have recently added to or reduced their stakes in AGL. J.Safra Asset Management Corp raised its position in shares of agilon health by 626.1% in the 2nd quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company's stock valued at $27,000 after buying an additional 3,625 shares in the last quarter. Neo Ivy Capital Management acquired a new stake in shares of agilon health in the 4th quarter valued at $47,000. CWM LLC increased its stake in shares of agilon health by 406.5% in the 2nd quarter. CWM LLC now owns 9,081 shares of the company's stock valued at $59,000 after purchasing an additional 7,288 shares during the last quarter. Nisa Investment Advisors LLC acquired a new position in shares of agilon health during the 2nd quarter worth $60,000. Finally, Bleakley Financial Group LLC bought a new stake in shares of agilon health during the 1st quarter worth $65,000.

agilon health Company Profile

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Featured Stories

Analyst Recommendations for agilon health (NYSE:AGL)

Should you invest $1,000 in agilon health right now?

Before you consider agilon health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.

While agilon health currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Post-Election Chaos or Opportunity? Prepare Your Investments
Strong Markets Meet Rising Volatility—Are Your Investments Safe?
Analysts Bullish on AI-Powered Healthcare: Intuitive Surgical’s 30% Upside

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines